ACT 📈 AlzChem - Overview

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A2YNT30

ACT: Chemicals, Supplements, Pharmaceuticals, Coatings, Ceramics, Gases

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. The company was founded in 1908 and is based in Trostberg, Germany. Web URL: https://www.alzchem.com

Additional Sources for ACT Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ACT Stock Overview

Market Cap in USD 648m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

ACT Stock Ratings

Growth 5y 80.9%
Fundamental 76.4%
Dividend 58.9%
Rel. Strength Industry 87249
Analysts -
Fair Price Momentum 64.45 EUR
Fair Price DCF 279.85 EUR

ACT Dividends

Dividend Yield 12m 2.11%
Yield on Cost 5y 6.98%
Annual Growth 5y 3.13%
Payout Consistency 93.8%

ACT Growth Ratios

Growth Correlation 3m 69.8%
Growth Correlation 12m 90.8%
Growth Correlation 5y 55.8%
CAGR 5y 26.81%
CAGR/Mean DD 5y 2.05
Sharpe Ratio 12m 2.07
Alpha 109.09
Beta 0.47
Volatility 36.22%
Current Volume 12.2k
Average Volume 20d 13k
What is the price of ACT stocks?
As of December 21, 2024, the stock is trading at EUR 57.00 with a total of 12,172 shares traded.
Over the past week, the price has changed by +0.69%, over one month by -3.00%, over three months by +40.58% and over the past year by +131.85%.
Is AlzChem a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, AlzChem (XETRA:ACT) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 76.39 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACT as of December 2024 is 64.45. This means that ACT is currently undervalued and has a potential upside of +13.07% (Margin of Safety).
Is ACT a buy, sell or hold?
AlzChem has no consensus analysts rating.
What are the forecast for ACT stock price target?
According to ValueRays Forecast Model, ACT AlzChem will be worth about 70.2 in December 2025. The stock is currently trading at 57.00. This means that the stock has a potential upside of +23.23%.
Issuer Forecast Upside
Wallstreet Target Price 72.7 27.5%
Analysts Target Price - -
ValueRay Target Price 70.2 23.2%